| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/17/2001 | US6262123 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 07/17/2001 | US6262110 Farnesyl-protein transferase inhibitors |
| 07/17/2001 | US6262107 Conjugated to a water soluble polyglutamic acid polymer |
| 07/17/2001 | US6262106 Adamantanecarboximidamide derivatives and their use as NMDA antagonists |
| 07/17/2001 | US6262104 Selective delta opioid agonists and antagonists |
| 07/17/2001 | US6262102 Eprosartan monohydrate |
| 07/17/2001 | US6262098 Estrogen receptor modulators |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262089 Using these compounds to treat diseases associated with amyloidosis, such as alzheimer's disease, maturity onset diabetes mellitus, familial amyloid polyneuropathy, scrapie, and kreuzfeld-jacob disease. |
| 07/17/2001 | US6262088 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 07/17/2001 | US6262087 Indane or dihydroindole derivatives |
| 07/17/2001 | US6262084 Compounds that inhibit the binding of integrins to their receptors |
| 07/17/2001 | US6262075 Piperidone tachykinin antagonists |
| 07/17/2001 | US6262073 Pharmaceutical methods of use of 5-substituted and 5,5 disubstituted-3,4-dihydroxy-2(5H)-furanones |
| 07/17/2001 | US6262067 Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions |
| 07/17/2001 | US6262066 High affinity ligands for nociceptin receptor ORL-1 |
| 07/17/2001 | US6262057 Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 07/17/2001 | US6262053 Effective for treating tumor cells and particularly effective to induce apoptosis in leukemia and breast tumor cells. |
| 07/17/2001 | US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 07/17/2001 | US6262043 Show inhibitory activity against steroid sulfatase and are useful in treating or preventing hormone dependent diseases. |
| 07/17/2001 | US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6262028 CONTAINING OXY-SUBSTITUTED AMIDINOBENZYL DERIVATIVES OF DIPEPTIDES FROM CYCLOHEXYLGLYCINE AND AZETIDINE-2-CARBOXYLIC ACID; ximelagatran |
| 07/17/2001 | US6262026 Chimeric proteins for use in transport of a selected substance into cells |
| 07/17/2001 | US6262024 Neuron regulatory factor for promoting neuron survival |
| 07/17/2001 | US6261818 Nucleotide sequence of cardiac-related ankyrin-repeat protein kinase; antisense agents; probes; primers; vectors; host cells; antibodies; diagnosis and treatment of cardiovascular disorders |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261596 Method to provide for production of hair coloring pigments in hair follicles |
| 07/17/2001 | US6261566 Cosmetic compositions containing mulberry extract and retinoids |
| 07/17/2001 | US6261544 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 07/17/2001 | CA2223023C N-hydroxyureas as antiinflammatory agents |
| 07/17/2001 | CA2160961C New tricyclic amide compounds, process for preparing the same and pharmaceutical compositions containing them |
| 07/17/2001 | CA2065040C Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 07/12/2001 | WO2001049885A1 EGS MOLECULES THAT SPECIFICALLY DOWNREGULATE bcl-xL EXPRESSION |
| 07/12/2001 | WO2001049869A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049851A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | WO2001049832A2 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | WO2001049741A2 A process for isolation of osteopontin from milk |
| 07/12/2001 | WO2001049717A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 07/12/2001 | WO2001049711A2 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | WO2001049703A2 Substituted sapogenins and their use |
| 07/12/2001 | WO2001049698A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use |
| 07/12/2001 | WO2001049696A1 N,o-amidomalonate platinum complexes |
| 07/12/2001 | WO2001049689A2 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
| 07/12/2001 | WO2001049687A2 Cyclohexene nucleic acids |
| 07/12/2001 | WO2001049683A1 Novel heteroaryl derivatives, their preparation and use |
| 07/12/2001 | WO2001049682A1 Condensed azepines as vasopressin agonists |
| 07/12/2001 | WO2001049680A1 Novel indole derivatives |
| 07/12/2001 | WO2001049678A1 Substituted phenyl-piperazine derivatives, their preparation and use |
| 07/12/2001 | WO2001049676A1 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof |
| 07/12/2001 | WO2001049675A1 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2-mediated disorders |
| 07/12/2001 | WO2001049674A2 Glycosidase inhibitors and preparation thereof |
| 07/12/2001 | WO2001049673A2 Compounds and methods for modulation of estrogen receptors |
| 07/12/2001 | WO2001049662A2 Carbazole derivatives as inhibitors of spla2 |
| 07/12/2001 | WO2001049661A1 5-THIA-φ-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
| 07/12/2001 | WO2001049657A1 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors |
| 07/12/2001 | WO2001049324A2 Novel colloid synthetic vectors for gene therapy |
| 07/12/2001 | WO2001049323A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049322A1 Product comprising a heterotrimeric g protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension |
| 07/12/2001 | WO2001049315A1 Combination therapy for the treatment of inflammatory and respiratory diseases |
| 07/12/2001 | WO2001049312A2 O-superfamily conotoxin peptides |
| 07/12/2001 | WO2001049311A1 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
| 07/12/2001 | WO2001049309A2 Combinations of growth factors and i: upa or i: mmp for the treatment of damaged tissue |
| 07/12/2001 | WO2001049308A1 Novel immune enhancing compositions |
| 07/12/2001 | WO2001049305A2 Process for obtaining thylakoids from plants, pure thylakoids and use thereof |
| 07/12/2001 | WO2001049304A2 Aqueous ionic solutions and their uses in particular in ophthalmology |
| 07/12/2001 | WO2001049294A1 Product for treating gynecomastia |
| 07/12/2001 | WO2001049292A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | WO2001049291A1 10,11-difluoromethylenedioxycamptothecin compounds with topoisomerase i inhibition |
| 07/12/2001 | WO2001049289A1 Pharmaceutical and veterinary uses of endothelin antagonists |
| 07/12/2001 | WO2001049288A1 Novel compounds and compositions as protease inhibitors |
| 07/12/2001 | WO2001049287A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 07/12/2001 | WO2001049285A1 Flavonoid drug and dosage form, its production and use |
| 07/12/2001 | WO2001049278A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis |
| 07/12/2001 | WO2001049274A2 Methods for pulmonary delivery of interleukin-2 |
| 07/12/2001 | WO2001049272A2 Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals |
| 07/12/2001 | WO2001049163A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | WO2001044207A8 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 07/12/2001 | WO2001012665A3 Helical cytokine zalpha48 |
| 07/12/2001 | WO2001008677A8 Methods of inhibiting osteoclast activity |
| 07/12/2001 | WO2001007087A8 Enzyme catalyzed anti-infective therapeutic agents |
| 07/12/2001 | WO2001000220A3 Lipoprotein lipase (lpl) variant therapeutics |
| 07/12/2001 | WO2000075278A9 Gene encoding nade, p75ntr-associated cell death executor and uses thereof |
| 07/12/2001 | WO2000074724A3 Conjugates comprising cytokines and nucleic acids for treating proliferating cells |
| 07/12/2001 | WO2000074722A3 Modification of biological elements |
| 07/12/2001 | WO2000061230A3 Estrogen receptors-beta antagonism and bone diseases |
| 07/12/2001 | WO2000041726A9 Noninvasive vascular therapy |
| 07/12/2001 | US20010007902 An oligonucleotide complementary to a region of the ribonucleotide component of telomerase attached to an activator of ribonuclease L (activator-antisense complex) which cleaves ribonuclotide portion of telomerase enzyme |
| 07/12/2001 | US20010007873 Compounds such as 4-(6-amino-pyridin-2-yl)-3-methoxyphenol as nitric oxide synthase inhibitors used to treat central nervous system disorders, inflammatory disorders, septic shock, etc... |
| 07/12/2001 | US20010007856 Method for preventing and treating at a superacute phase, against neurological deficits or neuronal death in brain ischemia and pathological conditions |
| 07/12/2001 | US20010007752 Genetic engineering; nucleic acids |
| 07/12/2001 | US20010007693 Food products having enhanced cocoa polyphenol content and processes for producing the same |
| 07/12/2001 | DE19963868A1 Neue substituierte Piperidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New substituted piperidines, pharmaceutical compositions containing them and methods for their preparation |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | DE19962828A1 Screeningsverfahren für Chemotherapeutika Screening method for chemotherapeutic agents |
| 07/12/2001 | DE19945351A1 Verfahren zum Auffinden und zur Isolierung pharmakologisch wirksamer Verbindungen aus Substanzgemischen sowie eine Vorrichtung zur Durchführung des Verfahrens A method for finding and isolating pharmacologically active compounds from substance mixtures, and an apparatus for carrying out the method |
| 07/12/2001 | CA2475413A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2475393A1 Compositions and methods for treating conditions responsive to estrogen |
| 07/12/2001 | CA2396688A1 Glycosidase inhibitors and methods of synthesizing same |